Parallelsessies NVVC Voorjaarscongres 2015
Voorzitters: M.M Vis en J.M. ten Berg
10:30 – 10:42
Drug eluting balloon versus conventional balloon predilatation in acute myocardial infarction undergoing endothelial progenitor cell-capture stent implantation: DEBORA
2 randomized multicenter trial
C. Camaro; J. JaspersFocks, M.A. Brouwer; T.J.F. ten Cate, M.H. van Wely; H.R. Gehlmann,
J.S. Bos; J.P. Ottervanger; A.W.J. van het Hof; A.T.M. Gosselink; J.H.E. Dambrink; M.J. de
Boer; H. Suryapranata (Radboudumc, Nijmegen)
10:43 – 10:55
Older Age is Associated with Overestimation of Coronary Artery Stenoses
N.M. Borren, J.P. Ottervanger, E.M. Engbers, A.W.J. van 't Hof (Isala, Zwolle)
10:56 – 11:08
One-year clinical outcome of patients treated with the Absorb bioresorbable vascular scaffold (BVS) in routine clinical practice
R.P. Kraak, M.E. Hassell, J.Elias, M.J. Grundeken, K.T. Koch, J.J Piek,J. Baan Jr, M.M. Vis,
J.G.P. Tijssen, J.P.S Henriques, R.J de Winter, J.J Wykrzykowska (AMC, Amsterdam)
11:09 – 11:21
Tailoring Antiplatelet Therapy in Patients with Stent Thrombosis Is Highly Effective to
Reduce Recurrence Rate of Stent Thrombosis and Cardiac Death
T.C. Godschalk; L.M. Willemsen; B. Zwart; C.M. Hackeng; J.M. ten Berg (St. Antonius
Hospital, Nieuwegein)
11:22 – 11:34
Circulating Neutrophil Extracellular Trap levels prior to pPCI predict impaired reperfusion and hyperemic flow in STEMI patients.
A.S.A. Autar; M. Kurata; E. Regar; M. Valgimigli; F.W.G. Leebeek; F. Zijlstra; M. P.M. de
Maat; H.M.M. van Beusekom (Erasmus MC, Rotterdam)
11:35 – 11:47
Long-term Clinical Outcomes of STEMI Patients Treated with Bioresorbable Vascular
Scaffold (BVS)
C. Felix; J.M. Fam; Y.Ishibashi; R. Diletti; B. Everaert; N. Mieghem; E. Regar; F. Zijlstra; Y.
Onuma; R.J.M. van Geuns (Erasmus MC, Rotterdam)
11:48 – 12:00
Long-term Clinical Outcome in ST- elevation Myocardial Infarct Patients With
Incomplete Revascularization after PPCI With and Without Urgent Revascularization
S. Imami; M. Bax; C. Schotborgh; A. Haasdijk; G. Bleeker; P. Oemrawsingh
(HagaZiekenhuis, The Hague)

Parallelsessies NVVC Voorjaarscongres 2015
Voorzitters: C.H. Peels en B.J. Bouma
10:30 – 10:42
TriGuardTMHD Embolic Deflection Device for Cerebral Protection During
Transcatheter Aortic Valve Replacement: the Results of “DEFLECT II Trial”.
M. Samim; B. van der Worp; P. Agostoni; J. Hendrikse; R.P.J. Budde; F. Nijhoff; F.
Ramjankhan; P. A. Doevendans; P.R. Stella (UMC-Utrecht)
10:43 – 10:55
Follow-up of Patients after Aortic Valve Replacement: Importance of Preoperative
Valve Anatomy
L. Cozijnsen; H.J. van der Zaag-Loonen; M.A. Cozijnsen; R.L. Braam; R.H. Heijmen; B.J.M.
Mulder (Gelre Hospital, Apeldoorn)
10:56 – 11:08
Thromboembolic Events after Transfemoral Aortic Valve Implantation
F. van Kesteren; E.M.A. Wiegerinck; A.C. van der Wal; R.N. Planken; K.T. Koch; M.M. Vis; J.
Baan (AMC, Amsterdam)
11:09 – 11:21
Pregnancy in Patients with a Mechanical Valve Prosthesis: Data from ROPAC
I.M. van Hagen; M.R. Johnson; R. Hall; J.W. Roos-Hesselink (Erasmus MC, Rotterdam)
11:22 – 11:34
Antithrombotic strategy after bioprosthetic aortic valve replacement in patients with sinus rhythm: evaluation of guideline implementation
S.J.van der Wall; V.A.W.M. Umans; J. Schotten; M Keijzers; R. Meijer-Huissen; M. Nierman;
E. Janssen; M.V. Huisman; A.B.A. Vonk (LUMC, Leiden)
11:35 – 11:47
Effect of Native Descending Thoracic Aorta Growth After Acute Type A Aortic
Dissection on Event Free Survival
M.V.Regeer; B.Martina; V.Kamperidis; M.I.M.Versteegh; R.J.M.Klautz; M.J.Schalij; J.J.Bax;
N.Ajmone Marsan; V.Delgado (Leids Universitair Medisch Centrum, Leiden)
11:48 – 12:00
Design Specific Patterns of Electrical Conduction Dynamics after Transcatheter Aortic
Valve Implantation
L. van Gils; S. Baart Y. Aga; P.P.T. de Jaegere; N.M.D.A. van Mieghem (Erasmus MC,
Rotterdam)

Parallelsessies NVVC Voorjaarscongres 2015
Voorzitters: P.G. Pieper en A.P.J. van Dijk
10:30 – 10:42
NOACs, Are They Safe in Congenital Heart Disease? First Results of an International
Multicenter Registry!
H. Yang; J.F. Heidendael; J.R. de Groot; R.J.G. Peters; G.Tj. Sieswerda; F.J. Meijboom; T.C.
Konings; G. Veen; M.C. Post; B.J. Bouma; B.J.M. Mulder (AMC, Amsterdam)
10:43 – 10:55
Associations of Matrix Metalloproteinases with Functional Outcome in Adult
Congenital Heart Disease
V.J.M. Baggen; J.A. Eindhoven; A.E. van den Bosch; M. Witsenburg; J.A.A.E. Cuypers; E.
Boersma; J.W. Roos-Hesselink (Erasmus MC, Rotterdam)
10:56 – 11:08
Functional Parameters or Biomarkers: Best Predictors for Prognosis in Adults with
Pulmonary Arterial Hypertension due to Congenital Heart Disease?
I.M. Blok; A.C.M.J. van Riel; M.J. Schuuring; R.H.A.C.M. de Bruin-Bon; A.P.J. van Dijk; E.S.
Hoendermis; A.H. Zwinderman; B.J. Mulder; B.J. Bouma (AMC, Amsterdam)
11:09 – 11:21
Prosthetic Material is an Important Risk Factor for Infective Endocarditis in Adult
Congenital Heart Disease – Results from a Prospective Study
J.M. Kuijpers; F.J. Meijboom; P.G. Pieper; H.W. Vliegen; E.O.F. van Gorselen; M.S.
Hulsbergen-Zwarts; B.J.M. Mulder; B.J. Bouma (AMC Amsterdam)
11:22 – 11:34
Prediction of Pulmonary Hypertension using Chest-Computed Tomography in Patients with Pulmonary Sarcoidosis
M.P. Huitema; M. Spee; S. Boerman; V.M.M. Vorselaars; R.J. Snijder; H.W. van Es; J.C.
Grutters; M.C. Post (St. Antonius Hospital Nieuwegein)
11:35 – 11:47
Predictors of Exercise Capacity in Fontan Patients
E.B.H.J. van Stratum; D. Wolff; T. Ebels; L.J. Wagenaar; R.M.F. Berger; J.P. van Melle
(UMCG, Groningen)
11:48 – 12:00
The “unnatural history” of valvular pulmonary stenosis: outcome up to 40 years after surgical repair
J.A.A.E. Cuypers; M.E. Menting; P. Opi ć ; E.M.W.J. Utens; W.A. Helbing; M. Witsenburg;
A.E. van den Bosch; R.T. van Domburg; F.J. Meijboom; A.J.J.C. Bogers; J.W. Roos-
Hesselink, (Erasmus MC Rotterdam)

Parallelsessies NVVC Voorjaarscongres 2015
Voorzitters: A.H.E.M. Maas en J.C.A. Hoorntje
10:30 – 10:42
Long-term Outcome of Super-Responders to Cardiac Resynchronization Therapy
A. Ghani, P.P.H.M. Delnoy, A. Adiyaman, J.P. Ottervanger, A.R. Ramdat Misier, J.J.J. Smit,
A. Elvan (Isala hospital, Zwolle)
10:43 – 10:55
Presence of Myocardial Scar does not Prevent Improvement in Myocardial Perfusion and Left Ventricular Function in Refractory Angina Patients Undergoing
Intramyocardial Bone Marrow Cell Injection
I. Mann; S.F. Rodrigo; J. van Ramshorst; S.L. Beeres; H.J. Lamb; H.M. Siebelink; R.J. van der Geest; W.E. Fibbe; M.J. Schalij; D.E. Atsma (LUMC, Leiden)
10:56 – 11:08
Prognostic Value of Adenosine Perfusion Cardiac Magnetic Resonance for the
Evaluation of Coronary Artery Disease in an Unselected Population
F.M. van Aalst; M.E. Hassell; R.N. Planken; A.M. Spijkerboer; M. Groenink; S.M. Boekholdt;
A. Hirsch (all Academic Medical Center, Amsterdam)
11:09 – 11:21
Incidence and Predictors for MACE in Patients Diagnosed with ‘Atypical Chest Pain’ at the Emergency Department of a Medium-Sized Non-Academic Hospital in The
Netherlands.
C.E. van der Meer; E.A. Badings; E. van ’t Riet; F.M.A.C. Martens (Deventer Hospital,
Deventer)
11:22 – 11:34
Closed, Not Cured! Continuing Risk of Pulmonary Hypertension After Shunt Repair
A.C.M.J. van Riel, I.M. Blok, A.H. Zwinderman, E.M.C.J. Wajon, A.S.J.M. Sadee, M. Bakkerde Boo, A.P.J. van Dijk, E.S. Hoendermis, R.K. Riezebos, B.J.M. Mulder, B.J. Bouma (AMC,
Amsterdam)
11:35 – 11:47
Validation of a 1-Hour Rule-out Protocol using High-Sensitivity Cardiac Troponin T in
Patients with Acute Chest Pain
S. de Vries – Spithoven; J.M. Poldervaart; R. Kuijs; J.B. Reitsma; A. Limburg; C.E.E. van
Ofwegen – Hanekamp (Diakonessenhuis, Utrecht); A.W. Hoes (Diakonessenhuis
Utrecht/UMC, Utrecht)
11:48 – 12:00
Atypical Symptoms and Abnormal Routine Cardiac Screening in Young Adults:
Various Presentation of Anomalous Coronary Artery from the Pulmonary Artery
D. Robbers-Visser; S.M. Boekholdt; A.P.C.M. Backx; A.M. Spijkerboer; M. Groenink; D.R.
Koolbergen; B.J. Bouma; B.J. Mulder (AMC, Amsterdam)